Sudden onset of a widespread asymptomatic rash - 23/10/13
Funding sources: None. |
|
Dr Brodell has received honoraria from Allergan, Galderma, 3M/Graceway Pharmaceuticals, GlaxoSmithKline/Stiefel, Dermik/BenzaClin Speaker Bureau, Novartis Pharmaceuticals Corporation, Sanofi-Aventis, Medicis Speaker's Bureau, PharmaDerm, a division of Nycomed US Inc, and Veregen Speakers Bureau. Dr Brodell has received consultant fees from Galderma Laboratories, LP, Medicis, Dow Pharmaceutical Sciences, and Promius. Dr Brodell has served on advisory boards for Dow Pharmaceutical Sciences and Nycomed US Inc and has participated in clinical trials for Genentech, Galderma, Abbott Laboratories, and Dow Pharmaceutical Sciences. The other authors reported no conflicts of interest. |
Vol 69 - N° 5
P. e215-e216 - novembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?